News

OFS Credit Company Shares NAV Insights for December 2024

OFS Credit Company Shares NAV Insights for December 2024

OFS Credit Company Announces NAV Estimate for December 2024

OFS Credit Company, Inc. (NASDAQ: OCCI), a prominent firm specializing in collateralized loan obligation (CLO) equity and debt securities, has revealed its estimated net asset value (NAV) per share as of the end of December 2024. With a market capitalization standing at $150 million, the company has successfully achieved a notable 25% return over the past year, coupled with an impressive 19.2% dividend yield.

Current NAV Per Share Projection

The management of OFS Credit has disclosed an unaudited NAV range of approximately $6.98 to $7.08 per share of common stock. It's important to note that this preliminary estimate is not final and may be subject to adjustments following the completion of the typical quarter-end financial closing procedures. As a snapshot of the company's financial status, this estimate does not encompass a comprehensive overview of the month's performance.

Factors Influencing Financial Performance

Variations in the estimated NAV for OFS Credit can arise due to numerous external factors. The company has expressed that changes in interest rates, inflation dynamics, and geopolitical situations, such as the conflict in Eastern Europe and tensions in the Middle East, could significantly impact its financial well-being. Additionally, the new U.S. presidential administration's policies along with potential market volatility resulting from a government shutdown should also be taken into account.

Insight into Future Earnings

Given these factors, OFS Credit cautions that the estimated NAV per share may diverge considerably from official future valuations, particularly from the assessment scheduled for January 31, 2025. This information will be provided in the company’s monthly report filed on Form N-PORT.

Management and Financial Indicators

The investment management of OFS Credit is under the watchful eye of OFS Capital Management, LLC (NASDAQ: OFS), which is based in Chicago with additional operational offices in New York and Los Angeles. According to recent evaluations, the company upholds a robust current ratio of 8.94, showcasing its healthy liquidity position, while it also trades at a P/E ratio of 8.06, pointing to potential investment appeal.

Company Structure and Goals

OFS Credit is a non-diversified, externally managed closed-end investment firm that aims primarily to generate current income, with secondary objectives focusing on capital appreciation through investments in CLO equity and debt securities. The firm highlights its strong liquidity and attractive shareholder dividends as fundamental strengths.

Final Note on Financial Data

The financial details disclosed are based on information provided by the management of OFS Credit and have not undergone audit or review processes by KPMG LLP, which implies that they do not offer any assurance regarding the preliminary data provided. This transparency is critical for investors seeking insights into the company's financial health.

Frequently Asked Questions

What is the estimated NAV for OFS Credit as of December 2024?

The estimated NAV ranges between $6.98 to $7.08 per share of common stock.

What are the primary objectives of OFS Credit Company?

The primary objective is to generate current income, with capital appreciation as a secondary goal.

Who manages the investment activities for OFS Credit?

Investment activities are managed by OFS Capital Management, LLC, a registered investment adviser.

What are the key financial indicators for OFS Credit?

OFS Credit features a current ratio of 8.94 and a P/E ratio of 8.06, indicating strong liquidity.

How does external market factors influence OFS Credit?

Market factors such as interest rates, inflation, and geopolitical events can significantly affect the firm's investment income and asset values.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 194

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 96

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Chime Joins S&P MidCap 400 Amid Merger Jostle

Updated Category News Views 194

Index Shake-Up: Who's In, Who's Out? Hold onto your hats, folks—big changes are coming to the S&P MidCap 400! Chime Financial Inc. is crashing the party, taking a seat at the table, as NorthWestern Energy Group gets the boot. Now, if that doesn’t grab your attention, I don’t know what will. You've got to appreciate the chaos and opportunities that come with a roster...

Continue Reading
IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 104

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 222

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 168

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 138

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 201

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Dana Concludes Tender Offers for Senior Notes

Updated Category News Views 130

An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...

Continue Reading

Top 5 Most Recently Viewed Articles

Transformative Innovations in AI-Driven Data Center Patenting

Updated Category News Views 238

Insights from the Latest PatentVest Pulse Report In an era where digital advancements are at an all-time high, PatentVest has unveiled their latest findings in the PatentVest Pulse Report. This enlightening report delves into the transformative trends emerging in the AI data center patent landscape. With growing demands for efficient data handling and innovative...

Continue Reading
TransUnion's Q4 Earnings Beat Expectations; Analysts React

Updated Category News Views 232

TransUnion's Impressive Fourth Quarter Earnings TransUnion reported upbeat earnings for the fourth quarter, showcasing a strong performance that caught the attention of market analysts. The company announced earnings of $1.07 per share, surpassing the analyst consensus estimate of $1.02. In addition, quarterly sales rose to $1.171 billion, exceeding expectations of $1.134...

Continue Reading
Tencent Music Entertainment Group Announces Q3 2025 Results Update

Updated Category News Views 333

Tencent Music Entertainment Group to Report Financial Results Tencent Music Entertainment Group (NYSE: TME), a prominent name in the realm of online music and audio entertainment, has made a significant announcement regarding its upcoming financial results. The company is gearing up to reveal its unaudited financial performance for the third quarter of 2025, a vital time...

Continue Reading
AiDash's New Leadership Team Drives Growth and Innovation

Updated Category News Views 132

AiDash's New Leadership Team Drives Growth and Innovation AiDash, an enterprise SaaS company focused on making critical infrastructure industries climate adaptive and resilient, has recently taken significant steps to expand its leadership team. This move comes at a vital time as the company continues to scale its operations, aiming to meet the rising demand for...

Continue Reading
Daily Market Insights: Trading Strategies for Major Stocks

Updated Category News Views 391

Daily Market Trading Strategies for Success Good morning, traders! Today, we’re diving into insights on crucial stocks such as SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA. Our goal is to discuss effective strategies and essential price levels to help you navigate the market with confidence. Market Analysis: Key Price Levels to Watch Using our exclusive formula at...

Continue Reading